Xuenan Xuan Selected Research

Immunosorbents

12/2020	Development and evaluation of an enzyme-linked immunosorbent assay based on recombinant TgSRS2 for serodiagnosis of Toxoplasma gondii infection in cats.
4/2014	Epidemiological investigation of equine piroplasmosis in China by enzyme-linked immunosorbent assays.
3/2013	Identification and characterization of an interspersed repeat antigen of Babesia microti (BmIRA).
3/2012	Enzyme-linked immunosorbent assays based on Neospora caninum dense granule protein 7 and profilin for estimating the stage of neosporosis.
6/2011	Identification and characterization of a novel secreted antigen 1 of Babesia microti and evaluation of its potential use in enzyme-linked immunosorbent assay and immunochromatographic test.
8/2010	Serodiagnosis of ovine toxoplasmosis in Mongolia by an enzyme-linked immunosorbent assay with recombinant Toxoplasma gondii matrix antigen 1.
8/2008	Epidemiological survey of Babesia gibsoni infection in dogs in Japan by enzyme-linked immunosorbent assay using B. gibsoni thrombospondin-related adhesive protein antigen.
8/2008	Serological survey of Neospora caninum infection among dogs in Japan through species-specific ELISA.
4/2008	Babesia gibsoni: Serodiagnosis of infection in dogs by an enzyme-linked immunosorbent assay with recombinant BgTRAP.
10/2007	A novel 57-kDa merozoite protein of Babesia gibsoni is a prospective antigen for diagnosis and serosurvey of canine babesiosis by enzyme-linked immunosorbent assay.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuenan Xuan Research Topics

Disease

66	Infections 01/2022 - 09/2002
28	Babesiosis (Piroplasmosis) 01/2022 - 09/2002
11	Tick-Borne Diseases (Tick-Borne Disease) 10/2021 - 07/2007
9	Toxoplasmosis 06/2021 - 05/2003
6	Cysts 06/2021 - 03/2008
6	Parasitic Diseases (Parasitic Disease) 11/2011 - 03/2009
5	Parasitemia 01/2015 - 07/2007
4	Malaria 01/2021 - 04/2010
3	Body Weight (Weight, Body) 01/2022 - 12/2014
3	Cryptosporidiosis 05/2011 - 04/2003
2	Tick Infestations 10/2020 - 09/2020
1	Coinfection 01/2022
1	Vector Borne Diseases 03/2021
1	Anaplasmosis 02/2021
1	Ehrlichiosis 02/2021
1	Theileriasis 02/2021
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2021
1	Spotted Fever Group Rickettsiosis (Rickettsialpox) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Animal Diseases 01/2020
1	Schistosomiasis (Bilharziasis) 02/2018
1	Schistosomiasis japonica 02/2018
1	Vivax Malaria 12/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Neoplasms (Cancer) 12/2015

Drug/Important Bio-Agent (IBA)

23	AntigensIBA 02/2018 - 09/2002
22	EnzymesIBA 12/2020 - 09/2002
20	ImmunosorbentsIBA 12/2020 - 09/2002
16	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2003
13	VaccinesIBA 06/2021 - 04/2003
11	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 01/2007
10	AntibodiesIBA 01/2020 - 10/2003
8	Pharmaceutical PreparationsIBA 01/2022 - 09/2010
7	tert-butylserineIBA 10/2021 - 06/2019
4	CytokinesIBA 01/2022 - 01/2012
4	ThrombospondinsIBA 01/2017 - 04/2008
4	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 04/2003
4	Surface Antigens (Surface Antigen)IBA 02/2011 - 03/2004
4	Indicators and Reagents (Reagents)IBA 08/2010 - 10/2003
3	Liposomes (Liposome)IBA 01/2015 - 06/2009
3	Immunoglobulin G (IgG)IBA 12/2014 - 12/2007
3	alpha-tocopherol transfer proteinIBA 04/2010 - 11/2009
3	Vitamin E FDA LinkGeneric 04/2010 - 11/2009
2	LatexIBA 12/2021 - 08/2010
2	Green Fluorescent ProteinsIBA 06/2021 - 06/2008
2	Biomarkers (Surrogate Marker)IBA 03/2021 - 02/2018
2	18S Ribosomal RNAIBA 01/2021 - 01/2018
2	Biological ProductsIBA 01/2021 - 01/2020
2	Interferon-gamma (Interferon, gamma)IBA 01/2012 - 09/2009
2	Recombinant ProteinsIBA 02/2011 - 04/2007
2	Synthetic Vaccines (Recombinant Vaccines)IBA 10/2010 - 04/2005
2	LactoferrinIBA 11/2008 - 11/2003
2	ribosomal protein P0IBA 12/2007 - 06/2007
1	naphthoquineIBA 01/2022
1	Clofazimine (Lamprene)FDA Link 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Atovaquone (Mepron)FDA Link 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	pyronaridineIBA 04/2021
1	Attenuated VaccinesIBA 01/2021
1	artemisinin (artemisinine)IBA 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2021
1	tafenoquineIBA 01/2021
1	tributyl phosphate (TBP)IBA 10/2020
1	tert-butylbicyclophosphorothionateIBA 01/2020
1	CytochromesIBA 01/2020
1	Caspase 2IBA 01/2020
1	PorinsIBA 01/2020
1	Caspase 8 (Caspase-8)IBA 01/2020
1	AntioxidantsIBA 02/2018
1	ThioredoxinsIBA 02/2018
1	AcaricidesIBA 01/2018
1	Alanine (L-Alanine)FDA Link 12/2017
1	Merozoite Surface Protein 1 (MSA1)IBA 12/2017
1	Threonine (L-Threonine)FDA Link 12/2017
1	CurcuminIBA 12/2015
1	Complementary DNA (cDNA)IBA 05/2015
1	Chemokine ReceptorsIBA 01/2015
1	Clodronic Acid (Clodronate)IBA 01/2015
1	Immunoglobulin Fc FragmentsIBA 12/2014
1	ProdrugsIBA 08/2014
1	Dihydroorotate DehydrogenaseIBA 03/2014
1	pyrimidineIBA 03/2014
1	Sialic AcidsIBA 11/2013
1	beta-Galactoside alpha-2,3-SialyltransferaseIBA 11/2013
1	GlycoconjugatesIBA 11/2013
1	Neuraminidase (Sialidase)IBA 11/2013
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2013
1	Serine Proteases (Serine Protease)IBA 10/2013
1	SubtilisinIBA 10/2013
1	Amino Acids FDA Link 01/2013
1	Freund's AdjuvantIBA 10/2012
1	Peptide FragmentsIBA 02/2012
1	amsonic acid (DAS)IBA 02/2012
1	Peptides (Polypeptides)IBA 02/2012
1	Antimicrobial PeptidesIBA 02/2012
1	Interleukin-2 (IL2)IBA 01/2012
1	Interleukin-12 (IL 12)IBA 01/2012

Therapy/Procedure

2	Therapeutics 04/2021 - 12/2015
1	Oral Administration 01/2022